The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Third Phase 3 trial in third type of lymphoma to show improvement in overall survival with an ADCETRIS-containing regimen
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
The product is used to treat amyotrophic lateral sclerosis
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Subscribe To Our Newsletter & Stay Updated
